. 2000 Nov;20(21):8198–8208. doi: 10.1128/mcb.20.21.8198-8208.2000

TABLE 2.

Viability of flies expressing UAS-su(s)ΔARM derivatives^a

su(s) transgene	Transformant line	sev-GAL4/UAS-su(s) progeny
		% of total		% Viability
		25°C	18°C	25°C	18°C
None	NA	55.9 (3)	55.4 (2)	100	100
wt	18A	33.1 (12)^*	46.4 (3)^***	59	84
	25A	20.9 (3)^**^	30.8 (4)^***	37	56
	27A	10.7 (8)^***	30.5 (5)^**	19	55
ΔARM1	15B	48.4 (5)^*	53.8 (1)^*	87	97
	19C	52.6 (1)^*	52.5 (4)^*	94	95
	28A	35.6 (2)^***	34.5 (4)^***	64	62
ΔARM2	1A	33.0 (2)^***	27.2 (5)^***	59	49
	4E	50.1 (3)^*	27.2 (7)^**	90	49
	40C	39.0 (10)^*	31.2 (3)^**^	70	56
ΔARM1,2	9B	49.4 (5)^*	49.4 (6)^*	88	89
	10C	54.5 (3)^*	56.7 (2)^*	97	102
	17A	45.2 (2)^**	46.0 (7)^*	81	83

Females homozygous for a UAS-su(s) transgene on the second chromosome were crossed with heterozygous males carrying a second chromosome insertion of the sev-GAL4 transgene and a second chromosome balancer marked with Cy. The vials were incubated at either 25 or 18°C. Control crosses between yw females from the injection stock, lacking a UAS-su(s) transgene, and sev-GAL4/Cy males were performed in parallel. The percentage of sev-GAL4/UAS-su(s) progeny was determined by calculating the percentage of progeny with straight wings. Viability was measured by determining the percentage of straight-winged progeny obtained from the experimental versus the control cross. Standard deviations are shown in parentheses. P values, calculated by Student's t test, indicate the probability that the number obtained from each experimental cross is the same as number from the control cross: ∗, P > 0.05 (not significantly different from the control); ∗∗, 0.05 > P < 0.01; ∗∗∗, 0.01 > P < 0.001; ∗∗∗∗, P < 0.001. NA, not applicable.